Working in the arena of neurological devices, NeuroDyne Inc develops brian-computer interface technology with a focus on the alleviation of seizure activity from children who suffer congenital Brian disease, adult seizure activity, and veterans who suffer brain damage. The technology is able to predict seizures 10-15 minutes before they occur and provide a therapeutic solution to epilepsy patients to eradicate the seizure. In addition to seizure prediction, the solution may have applications for other brain pathologies such as Alzheimers, Depression, Schizophrenia, Parkinsons and others. Current epilepsy treatment involves prescription of anti-epileptic drugs (AEDs) that control seizures in 70% of patients, as well as other solutions less effective, however this solution would be effective in all patient
